Rizwana Kitchlew, Miqdad Haider, Sidra Batool, Faizan Farooq, Muhammad Shamim Ul Husnain


Background: Diabetes mellitus is the metabolic state which has shown a persistent global rise in numbers. It is therefore necessary to closely assess all aspects of this state. Sleep quality and diabetic control have a relation where both can affect each other. Therefore, we aim to study the quality of sleep and factors affecting it in our diabetic population. The objective of the study was the identification of quality of sleep and factors affecting it in the diabetic and non diabetic adult population. Methods: In this comparative cross sectional study quality of sleep was evaluated in all the patients through the Pittsburgh Sleep Quality Index. Statistical analysis was conducted with the SPSS-23. Results: The total number of study participants were 250 adults (18 years and above), where 125 were diabetics, while 125 were non diabetics. In Diabetic group, the total number of patients with impaired sleep was 65 (52%). In non-diabetic group, impaired sleep was found in 70 (56%) individuals. The mean age of diabetics was 55.2±11.6 years and non-diabetics was 37.23±12.017 years. Prevalence of restless leg syndrome and depression among diabetics was 33 (26.4%) and 30 (24.0%) respectively and in non-diabetic was 20 (16.0%) and 63 (50.4%). Impaired sleep quality was associated with the use of cell phones before going to bed (p-value: 0.01) and watching television until late at night in both groups. Impaired sleep is seen more commonly in uncontrolled DM (RR:1.462 and CI: 0.531 to 4.025) Conclusion: Impaired sleep and uncontrolled DM has a direct relation and the prevalence of Restless leg syndrome (RLS) is higher in Diabetics. Addressing the factors impairing sleep can improve sleep quality and have beneficial effects on the sufferers from this metabolic state.

Keywords: Sleep; Diabetes Mellitus; Restless leg syndrome; Depression; Cell phone

Full Text:



Anothaisintawee T, Reutrakul S, Van Cauter E, Thakkinstian A. Sleep disturbances compared to traditional risk factors for diabetes development: systematic review and meta-analysis. Sleep Med Rev 2016;30:11–24.

Spiegel K, Knutson K, Leproult R, Tasali E, Cauter EV. Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes. J Appl Physiol 2005;99(5):2008–19.

Spiegel K, Tasali E, Leproult R, Van Cauter E. Effects of poor and short sleep on glucose metabolism and obesity risk. Nat Rev Endocrinol 2009;5(5):253.

Nichols G. Assess patients with diabetes for sleep quality. [Internet] Medscape. [cited 2019 Oct 24]. Available from: https://www.medscape.com/viewarticle/878492

Cappuccio FP, D'Elia L, Strazzullo P, Miller MA. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care 2010;33(2):414–20.

Barone MT, Menna-Barreto L. Diabetes and sleep: a complex cause-and-effect relationship. Diabetes Res Clin Pract 2011;91(2):129–37.

Shaulova E. Diabetics number top countries 2017. [Internet] Statista. 2017 [cited 2019 Oct 24]. Available from: https://www.statista.com/statistics/281082/countries-with-highest-number-of-diabetics/

Aamir A, Ul-Haq Z, Mahar S, Qureshi F, Ahmad I, Jawa A, et al. Diabetes Prevalence Survey of Pakistan (DPS-PAK): prevalence of type 2 diabetes mellitus and prediabetes using HbA1c: a population-based survey from Pakistan. BMJ Open 2019;9(2):e025300.

Smyth C. The Pittsburgh sleep quality index (PSQI). J Gerontol Nurs 1999;25(12):10–1.

Löwe B, Kroenke K, Gräfe K. Detecting and monitoring depression with a two-item questionnaire (PHQ-2). J Psychosom Res 2005;58(2):163–71.

Allen RP, Picchietti DL, Garcia-Borreguero D, Ondo WG, Walters AS, Winkelman JW, et al. International Restless Legs Syndrome Study Group. Restless legs syndrome/Willis–Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria–history, rationale, description, and significance. Sleep Med 2014;15(8):860–73.

Liu X, Tang M, Hu L. Reliability and validity of the Pittsburgh sleep quality index. Chin J Psychiatry 1996;29:103–7.

Luyster FS, Dunbar-Jacob J. Sleep quality and quality of life in adults with type 2 diabetes. Diabetes Educ 2011;37(3):347–55.

Jemere T, Mossie A, Berhanu H, Yeshaw Y. Poor sleep quality and its predictors among type 2 diabetes mellitus patients attending Jimma University Medical Center, Jimma, Ethiopia. BMC Res Notes 2019;12(1):488.

Rajendran A, Parthsarathy S, Tamilselvan B, Seshadri KG, Shuaib M. Prevalence and correlates of disordered sleep in southeast asian indians with type 2 diabetes. Diabetes Metabol J 2012;36(1):70–6.

Cunha MC, Zanetti ML, Hass VJ. Sleep quality in type 2 diabetic Rev Lat Am Enfermagem 2008;16(5):850–5.

Feng P, Chen M, Hu JW, Guo ZR, Tong WJ, ZhangYH, et al. The impact of physical, psychological and social adaptation status on sleep quality among people age 18 to 55 in Suzhou. Chin J Epidemiol 2012;33(1):119–20.

Thomée S, Härenstam A, Hagberg M. Mobile phone use and stress, sleep disturbances, and symptoms of depression among young adults-a prospective cohort study. BMC Public Health 2011;11(1):66.

Zhu BQ, Li XM, Wang D, Yu XF. Sleep quality and its impact on glycaemic control in patients with type 2 diabetes mellitus. Int J Nurs Sci 2014;1(3):260–5.

Vigg A, Vigg A, Vigg A. Sleep in Type 2 diabetes. J Assoc Physicians India 2003;51:479–81.

Yaltho TC, Ondo WG. The use of gabapentin enacarbil in the treatment of restless legs syndrome. Ther Adv Neurol Disord 2010;3(5):269–75.

Kim TJ, Yoon JE, Park JA, Lee SK, Chu MK, Yang KI, et al. Prevalence and Characteristics of Restless Legs Syndrome in Korean Adults: A Study in Two Independent Samples of the General Population. Neuroepidemiology 2019;52(3-4):193–204.

Rangarajan S, Rangarajan S, D’Souza GA. Restless legs syndrome in an Indian urban population. Sleep Med 2007;9(1):88–93.

Panda S, Taly AB, Sinha S, Gururaj G, Girish N, Nagaraja D. Sleep-related disorders among a healthy population in South India. Neurol India 2012;60(1):68.

Zobeiri M, Shokoohi A. Restless leg syndrome in diabetics compared with normal controls. Sleep Disord 2014;2014:871751.

Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care 2003;1:1284–92.

Golden SH, Lazo M, Carnethon M, Bertoni AG, Schreiner PJ, Roux AV, et al. Examining a bidirectional association between depressive symptoms and diabetes. JAMA 2008;299(23):2751–9.

Salinero-Fort MA, Gómez-Campelo P, San Andrés-Rebollo FJ, Cárdenas-Valladolid J, Abánades-Herranz JC, de Santa Pau EC, et al. Prevalence of depression in patients with type 2 diabetes mellitus in Spain (the DIADEMA Study): results from the MADIABETES cohort. BMJ Open 2018;8(9):e020768.

Lunghi C, Moisan J, Grégoire JP, Genette L. Incidence of depression and associated factors in patients with type 2 diabetes in Quebec, Canada: a population-based cohort study. Medicine 2016;95(21):e3514.

Hasan SS, Mamun AA, Clavarino AM, Kairuz T. Incidence and risk of depression associated with diabetes in adults: evidence from longitudinal studies. Community Ment Health J 2015;51(2):204–10.


  • There are currently no refbacks.

Contact Number: +92-992-382571

email: [jamc] [@] [ayubmed.edu.pk]